Publication | Open Access
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings
10
Citations
5
References
2022
Year
Skinny-label BiosimilarsConsumer ResearchHealth Care FinanceAssociated Medicare SavingsBiobankHealthcare MarketingManagementSkinny LabelRandomized Controlled TrialRegulatory ConsiderationPublic HealthHealth Services ResearchConsumer HealthHealth PolicyBioequivalenceHealth InsurancePharmacoeconomicsCohort StudyMarketingRegulatory ApprovalHealth EconomicsHealth Services CompetitionMedicine
This cohort study assesses the frequency of approval and marketing of skinny-label biosimilars and their savings to Medicare.
| Year | Citations | |
|---|---|---|
Page 1
Page 1